

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 6.19992589 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.51049429 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.24072691 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.24072691 |
| 5 | regulation of gene silencing by RNA (GO:0060966) | 5.18223968 |
| 6 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.18223968 |
| 7 | regulation of gene silencing by miRNA (GO:0060964) | 5.18223968 |
| 8 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.87012839 |
| 9 | formation of translation preinitiation complex (GO:0001731) | 4.84777086 |
| 10 | regulation of translational fidelity (GO:0006450) | 4.58933616 |
| 11 | nuclear pore organization (GO:0006999) | 4.56525093 |
| 12 | regulation of translational termination (GO:0006449) | 4.49958395 |
| 13 | heterochromatin organization (GO:0070828) | 4.47423878 |
| 14 | mitotic nuclear envelope disassembly (GO:0007077) | 4.38386737 |
| 15 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.38327398 |
| 16 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.38327398 |
| 17 | protein localization to kinetochore (GO:0034501) | 4.38269348 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 4.24393768 |
| 19 | nuclear envelope disassembly (GO:0051081) | 4.16065322 |
| 20 | membrane disassembly (GO:0030397) | 4.16065322 |
| 21 | nuclear pore complex assembly (GO:0051292) | 4.14752424 |
| 22 | pre-miRNA processing (GO:0031054) | 4.12290575 |
| 23 | IMP biosynthetic process (GO:0006188) | 4.06059500 |
| 24 | pentose-phosphate shunt (GO:0006098) | 3.96571407 |
| 25 | nucleobase biosynthetic process (GO:0046112) | 3.92425051 |
| 26 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.90729231 |
| 27 | mitotic sister chromatid segregation (GO:0000070) | 3.90688551 |
| 28 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.89435066 |
| 29 | mitotic nuclear envelope reassembly (GO:0007084) | 3.87356387 |
| 30 | nuclear envelope reassembly (GO:0031468) | 3.87356387 |
| 31 | histone arginine methylation (GO:0034969) | 3.87268917 |
| 32 | DNA replication initiation (GO:0006270) | 3.73286404 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.67254197 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.66466362 |
| 35 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.65299096 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 3.64628379 |
| 37 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.63776486 |
| 38 | NADPH regeneration (GO:0006740) | 3.62429120 |
| 39 | paraxial mesoderm development (GO:0048339) | 3.60739361 |
| 40 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60371539 |
| 41 | mitotic metaphase plate congression (GO:0007080) | 3.60358896 |
| 42 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.59310958 |
| 43 | establishment of viral latency (GO:0019043) | 3.56507721 |
| 44 | protein localization to chromosome, centromeric region (GO:0071459) | 3.55516273 |
| 45 | sister chromatid segregation (GO:0000819) | 3.54152974 |
| 46 | protein localization to endosome (GO:0036010) | 3.51568479 |
| 47 | pinocytosis (GO:0006907) | 3.49976685 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.48520371 |
| 49 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47887828 |
| 50 | purine nucleobase biosynthetic process (GO:0009113) | 3.47774472 |
| 51 | barbed-end actin filament capping (GO:0051016) | 3.46964412 |
| 52 | regulation of hippo signaling (GO:0035330) | 3.46871770 |
| 53 | glucose catabolic process (GO:0006007) | 3.43861599 |
| 54 | NADH metabolic process (GO:0006734) | 3.41824680 |
| 55 | ribosome biogenesis (GO:0042254) | 3.40664997 |
| 56 | establishment of integrated proviral latency (GO:0075713) | 3.39184011 |
| 57 | IMP metabolic process (GO:0046040) | 3.39116216 |
| 58 | establishment of apical/basal cell polarity (GO:0035089) | 3.38792441 |
| 59 | DNA duplex unwinding (GO:0032508) | 3.36104299 |
| 60 | peptidyl-arginine methylation (GO:0018216) | 3.35571205 |
| 61 | peptidyl-arginine N-methylation (GO:0035246) | 3.35571205 |
| 62 | DNA strand elongation (GO:0022616) | 3.35357266 |
| 63 | DNA geometric change (GO:0032392) | 3.35348153 |
| 64 | nuclear envelope organization (GO:0006998) | 3.34755055 |
| 65 | ribosome assembly (GO:0042255) | 3.34117482 |
| 66 | histone H4-K12 acetylation (GO:0043983) | 3.33478399 |
| 67 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.33185949 |
| 68 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.33156339 |
| 69 | pentose metabolic process (GO:0019321) | 3.31817392 |
| 70 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.31339010 |
| 71 | pore complex assembly (GO:0046931) | 3.30512983 |
| 72 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.29822168 |
| 73 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.29822168 |
| 74 | mitochondrial fusion (GO:0008053) | 3.28152395 |
| 75 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.27903022 |
| 76 | DNA replication checkpoint (GO:0000076) | 3.26925508 |
| 77 | folic acid metabolic process (GO:0046655) | 3.24196295 |
| 78 | regulation of spindle organization (GO:0090224) | 3.20665478 |
| 79 | positive regulation of chromosome segregation (GO:0051984) | 3.17896534 |
| 80 | chromatin assembly (GO:0031497) | 3.17428914 |
| 81 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.16228728 |
| 82 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.14491422 |
| 83 | regulation of mitotic spindle organization (GO:0060236) | 3.14124020 |
| 84 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.12148068 |
| 85 | proline biosynthetic process (GO:0006561) | 3.09551343 |
| 86 | mitotic G1/S transition checkpoint (GO:0044819) | 3.09337127 |
| 87 | apoptotic process involved in morphogenesis (GO:0060561) | 3.04859722 |
| 88 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.04189323 |
| 89 | chaperone-mediated protein complex assembly (GO:0051131) | 3.00517073 |
| 90 | negative regulation of histone methylation (GO:0031061) | 3.00348674 |
| 91 | trophectodermal cell differentiation (GO:0001829) | 2.97488750 |
| 92 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.95410437 |
| 93 | dosage compensation (GO:0007549) | 2.93314671 |
| 94 | regulation of mitochondrial membrane potential (GO:0051881) | 2.92052179 |
| 95 | mitochondrial DNA metabolic process (GO:0032042) | 2.90177253 |
| 96 | negative regulation of ligase activity (GO:0051352) | 2.89692609 |
| 97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.89692609 |
| 98 | regulation of sister chromatid cohesion (GO:0007063) | 2.89253092 |
| 99 | negative regulation of cell size (GO:0045792) | 2.89237277 |
| 100 | nodal signaling pathway (GO:0038092) | 2.88800512 |
| 101 | pyrimidine-containing compound salvage (GO:0008655) | 2.88649486 |
| 102 | pyrimidine nucleoside salvage (GO:0043097) | 2.88649486 |
| 103 | mitotic chromosome condensation (GO:0007076) | 2.88499341 |
| 104 | virion assembly (GO:0019068) | 2.88112650 |
| 105 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.87010855 |
| 106 | regulation of translational elongation (GO:0006448) | 2.86330155 |
| 107 | establishment of monopolar cell polarity (GO:0061162) | 2.86181363 |
| 108 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.86181363 |
| 109 | negative regulation of chromosome segregation (GO:0051985) | 2.86048905 |
| 110 | UV protection (GO:0009650) | 2.86014859 |
| 111 | regulation of centrosome cycle (GO:0046605) | 2.85836957 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.84902462 |
| 113 | metaphase plate congression (GO:0051310) | 2.84398267 |
| 114 | regulation of gene silencing (GO:0060968) | 2.83752172 |
| 115 | anterior/posterior axis specification, embryo (GO:0008595) | 2.83054972 |
| 116 | determination of adult lifespan (GO:0008340) | 2.82784103 |
| 117 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.81666110 |
| 118 | regulation of chromosome segregation (GO:0051983) | 2.80478820 |
| 119 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.80116307 |
| 120 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.78295876 |
| 121 | regulation of mitochondrial translation (GO:0070129) | 2.78271187 |
| 122 | maternal placenta development (GO:0001893) | 2.77749363 |
| 123 | negative regulation of gene silencing (GO:0060969) | 2.76697533 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75757618 |
| 125 | G1 DNA damage checkpoint (GO:0044783) | 2.75372741 |
| 126 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.74488863 |
| 127 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.74488863 |
| 128 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.74488863 |
| 129 | tetrahydrofolate metabolic process (GO:0046653) | 2.74228522 |
| 130 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72954672 |
| 131 | regulation of early endosome to late endosome transport (GO:2000641) | 2.72414375 |
| 132 | maturation of SSU-rRNA (GO:0030490) | 2.72058758 |
| 133 | regulation of superoxide anion generation (GO:0032928) | 2.70756575 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.70633021 |
| 135 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.70552269 |
| 136 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.69398325 |
| 137 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.69169205 |
| 138 | regulation of histone H3-K9 methylation (GO:0051570) | 2.68338597 |
| 139 | mitochondrial calcium ion transport (GO:0006851) | 2.68221778 |
| 140 | histone H2A monoubiquitination (GO:0035518) | 2.65898914 |
| 141 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.64971698 |
| 142 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64341746 |
| 143 | protein complex localization (GO:0031503) | 2.64266868 |
| 144 | tRNA aminoacylation for protein translation (GO:0006418) | 2.64172468 |
| 145 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.64144017 |
| 146 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.64144017 |
| 147 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.64144017 |
| 148 | negative regulation of sister chromatid segregation (GO:0033046) | 2.64144017 |
| 149 | DNA deamination (GO:0045006) | 2.63304953 |
| 150 | viral protein processing (GO:0019082) | 2.62918217 |
| 151 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.62845507 |
| 152 | heme biosynthetic process (GO:0006783) | 2.62406989 |
| 153 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.60155964 |
| 154 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.58162817 |
| 155 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.58162817 |
| 156 | glycosphingolipid catabolic process (GO:0046479) | 2.55858547 |
| 157 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55705721 |
| 158 | protein targeting to mitochondrion (GO:0006626) | 2.54490540 |
| 159 | negative regulation of mitochondrion organization (GO:0010823) | 2.53617537 |
| 160 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53449924 |
| 161 | cellular response to arsenic-containing substance (GO:0071243) | 2.51481686 |
| 162 | monosaccharide biosynthetic process (GO:0046364) | 2.50825036 |
| 163 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.48481680 |
| 164 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.48481680 |
| 165 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.46272695 |
| 166 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.45286418 |
| 167 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.45286418 |
| 168 | ribosomal small subunit biogenesis (GO:0042274) | 2.44642229 |
| 169 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.44001937 |
| 170 | amino sugar catabolic process (GO:0046348) | 2.41743230 |
| 171 | de novo protein folding (GO:0006458) | 2.41543148 |
| 172 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.40950852 |
| 173 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.40658800 |
| 174 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.40658800 |
| 175 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.40658800 |
| 176 | de novo posttranslational protein folding (GO:0051084) | 2.40563859 |
| 177 | nucleotide salvage (GO:0043173) | 2.40560224 |
| 178 | glucose 6-phosphate metabolic process (GO:0051156) | 2.40058771 |
| 179 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.39491786 |
| 180 | rRNA transcription (GO:0009303) | 2.39276440 |
| 181 | positive regulation of nuclease activity (GO:0032075) | 2.38661716 |
| 182 | iron-sulfur cluster assembly (GO:0016226) | 2.38408798 |
| 183 | metallo-sulfur cluster assembly (GO:0031163) | 2.38408798 |
| 184 | chaperone-mediated protein transport (GO:0072321) | 2.36851645 |
| 185 | nucleoside salvage (GO:0043174) | 2.36553781 |
| 186 | positive regulation of ligase activity (GO:0051351) | 2.36142436 |
| 187 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.36133311 |
| 188 | hydrogen peroxide catabolic process (GO:0042744) | 2.35473088 |
| 189 | proteasome assembly (GO:0043248) | 2.34404194 |
| 190 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.34256076 |
| 191 | amyloid precursor protein catabolic process (GO:0042987) | 2.34211526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.09623022 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.81903780 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.55229489 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.46321157 |
| 5 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.86945845 |
| 6 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.51849183 |
| 7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.51133470 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.48053074 |
| 9 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.39368998 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32786506 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.30871705 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25585072 |
| 13 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.12265934 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10428841 |
| 15 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.09221412 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.08826665 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08776568 |
| 18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.08548621 |
| 19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.08548621 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.08548621 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06727260 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04891726 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.04068342 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.02278736 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.00072597 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.96697733 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92147048 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.90972383 |
| 29 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.81035874 |
| 30 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.80204215 |
| 31 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80186427 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76328450 |
| 33 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73127981 |
| 34 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.71210426 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68748063 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68109363 |
| 37 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66533614 |
| 38 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.66486566 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65041991 |
| 40 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.60456997 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59789624 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59526287 |
| 43 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.58709314 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56518566 |
| 45 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.56474044 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55597729 |
| 47 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54446196 |
| 48 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.53405627 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52440900 |
| 50 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.50483114 |
| 51 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49539098 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49128578 |
| 53 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46982021 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46576220 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.46315312 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.45721888 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45165854 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44987871 |
| 59 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44141697 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44062959 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41714476 |
| 62 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.41710531 |
| 63 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.41569077 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.41139689 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41063435 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.39419638 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39213797 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38010981 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37054572 |
| 70 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.37013590 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36550219 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35058166 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34840514 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33958464 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33547149 |
| 76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32036383 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30865461 |
| 78 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.30693887 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29603008 |
| 80 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.28922996 |
| 81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.28474426 |
| 82 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.27632059 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.27466176 |
| 84 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27195767 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 1.26895570 |
| 86 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26538695 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23459665 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21928003 |
| 89 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.20667125 |
| 90 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20073738 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19195841 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19114860 |
| 93 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.18683190 |
| 94 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.17508628 |
| 95 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.17298241 |
| 96 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.16848453 |
| 97 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.16548793 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16374045 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15687842 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15446191 |
| 101 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15001398 |
| 102 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14168203 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13647284 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12877973 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12655580 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12077117 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11441721 |
| 108 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11215168 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11120686 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10120801 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09226096 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08231436 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08212485 |
| 114 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.08111141 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07906723 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07836003 |
| 117 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.07452466 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.06827861 |
| 119 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05968930 |
| 120 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.05834899 |
| 121 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05399028 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04075477 |
| 123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03921739 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03572932 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03306022 |
| 126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02820861 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02782997 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02777933 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.02468699 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01909501 |
| 131 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00920733 |
| 132 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00622615 |
| 133 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00413408 |
| 134 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00352468 |
| 135 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99429893 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98624418 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98567381 |
| 138 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95449863 |
| 139 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95002269 |
| 140 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94982686 |
| 141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94898836 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92256779 |
| 143 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91542416 |
| 144 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.91041235 |
| 145 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.89413105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.85292631 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.94934231 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.94364334 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.77490831 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.74767792 |
| 6 | MP0008260_abnormal_autophagy | 3.32746554 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.23657575 |
| 8 | MP0010094_abnormal_chromosome_stability | 3.17750764 |
| 9 | MP0003077_abnormal_cell_cycle | 3.09882677 |
| 10 | MP0002653_abnormal_ependyma_morphology | 3.07175014 |
| 11 | MP0005451_abnormal_body_composition | 3.05595833 |
| 12 | MP0001730_embryonic_growth_arrest | 2.79949751 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.53195794 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.44568152 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.43523824 |
| 16 | MP0010307_abnormal_tumor_latency | 2.42305935 |
| 17 | MP0003283_abnormal_digestive_organ | 2.38155510 |
| 18 | MP0003123_paternal_imprinting | 2.37691805 |
| 19 | MP0008057_abnormal_DNA_replication | 2.30143344 |
| 20 | MP0003303_peritoneal_inflammation | 2.29596409 |
| 21 | MP0000350_abnormal_cell_proliferation | 2.28893563 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.15495589 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.11273197 |
| 24 | MP0001672_abnormal_embryogenesis/_devel | 2.09647186 |
| 25 | MP0005380_embryogenesis_phenotype | 2.09647186 |
| 26 | MP0008932_abnormal_embryonic_tissue | 2.04919373 |
| 27 | MP0001697_abnormal_embryo_size | 2.01542188 |
| 28 | MP0004510_myositis | 2.01124317 |
| 29 | MP0002084_abnormal_developmental_patter | 1.99389460 |
| 30 | MP0010030_abnormal_orbit_morphology | 1.97627182 |
| 31 | MP0002085_abnormal_embryonic_tissue | 1.95497644 |
| 32 | MP0004233_abnormal_muscle_weight | 1.95404405 |
| 33 | MP0004197_abnormal_fetal_growth/weight/ | 1.94773886 |
| 34 | MP0003075_altered_response_to | 1.94342052 |
| 35 | MP0000343_altered_response_to | 1.93940137 |
| 36 | MP0003984_embryonic_growth_retardation | 1.89124391 |
| 37 | MP0004133_heterotaxia | 1.88186918 |
| 38 | MP0003329_amyloid_beta_deposits | 1.87447635 |
| 39 | MP0002088_abnormal_embryonic_growth/wei | 1.86462144 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.86425270 |
| 41 | MP0002086_abnormal_extraembryonic_tissu | 1.86162815 |
| 42 | * MP0002080_prenatal_lethality | 1.82638961 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.80825527 |
| 44 | MP0002796_impaired_skin_barrier | 1.79250770 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.78832663 |
| 46 | MP0003119_abnormal_digestive_system | 1.77830631 |
| 47 | MP0008058_abnormal_DNA_repair | 1.76800329 |
| 48 | MP0001849_ear_inflammation | 1.70062641 |
| 49 | MP0003436_decreased_susceptibility_to | 1.56706115 |
| 50 | MP0003890_abnormal_embryonic-extraembry | 1.56169669 |
| 51 | MP0005165_increased_susceptibility_to | 1.53532216 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.49523309 |
| 53 | MP0000604_amyloidosis | 1.42386663 |
| 54 | MP0002269_muscular_atrophy | 1.41523831 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.40909846 |
| 56 | MP0001853_heart_inflammation | 1.39467381 |
| 57 | MP0001293_anophthalmia | 1.36771242 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.36275037 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.35398780 |
| 60 | MP0002254_reproductive_system_inflammat | 1.34310911 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.32108108 |
| 62 | MP0004947_skin_inflammation | 1.31994627 |
| 63 | MP0005023_abnormal_wound_healing | 1.31724936 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.31097771 |
| 65 | MP0004858_abnormal_nervous_system | 1.26361856 |
| 66 | MP0000313_abnormal_cell_death | 1.25857631 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.25613819 |
| 68 | MP0009053_abnormal_anal_canal | 1.25302414 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.22044503 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.22044503 |
| 71 | MP0000537_abnormal_urethra_morphology | 1.20502620 |
| 72 | MP0000358_abnormal_cell_content/ | 1.18815866 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.17852337 |
| 74 | MP0009840_abnormal_foam_cell | 1.16717217 |
| 75 | MP0005330_cardiomyopathy | 1.16143659 |
| 76 | MP0001542_abnormal_bone_strength | 1.15778067 |
| 77 | MP0001727_abnormal_embryo_implantation | 1.13999838 |
| 78 | MP0003786_premature_aging | 1.12865343 |
| 79 | MP0000749_muscle_degeneration | 1.12576131 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.11615784 |
| 81 | MP0002060_abnormal_skin_morphology | 1.11142675 |
| 82 | MP0009672_abnormal_birth_weight | 1.11123963 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.06882209 |
| 84 | MP0000490_abnormal_crypts_of | 1.06663334 |
| 85 | MP0002019_abnormal_tumor_incidence | 1.06559423 |
| 86 | MP0000003_abnormal_adipose_tissue | 1.05629135 |
| 87 | MP0000733_abnormal_muscle_development | 1.04915104 |
| 88 | MP0009278_abnormal_bone_marrow | 1.03979574 |
| 89 | MP0009703_decreased_birth_body | 1.02922514 |
| 90 | MP0002111_abnormal_tail_morphology | 1.02076682 |
| 91 | MP0001661_extended_life_span | 1.01605309 |
| 92 | MP0001216_abnormal_epidermal_layer | 1.01191684 |
| 93 | MP0000751_myopathy | 1.00214509 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.99148208 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.98521819 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.96807657 |
| 97 | MP0001243_abnormal_dermal_layer | 0.93159364 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 0.92640319 |
| 99 | MP0005384_cellular_phenotype | 0.92506422 |
| 100 | MP0005621_abnormal_cell_physiology | 0.92309145 |
| 101 | MP0005083_abnormal_biliary_tract | 0.91969533 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.91830435 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91003097 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.90330335 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.90267352 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.89796402 |
| 107 | MP0008770_decreased_survivor_rate | 0.88394372 |
| 108 | MP0005266_abnormal_metabolism | 0.88159112 |
| 109 | MP0008874_decreased_physiological_sensi | 0.87673823 |
| 110 | MP0005025_abnormal_response_to | 0.86645917 |
| 111 | MP0002419_abnormal_innate_immunity | 0.85628541 |
| 112 | MP0000371_diluted_coat_color | 0.85058235 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.84729500 |
| 114 | MP0003878_abnormal_ear_physiology | 0.84729500 |
| 115 | MP0001915_intracranial_hemorrhage | 0.84572400 |
| 116 | MP0003718_maternal_effect | 0.82826954 |
| 117 | MP0005166_decreased_susceptibility_to | 0.82763476 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.82431207 |
| 119 | MP0001145_abnormal_male_reproductive | 0.81516287 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.81324006 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.80749134 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.80442832 |
| 123 | MP0006082_CNS_inflammation | 0.80276344 |
| 124 | MP0002697_abnormal_eye_size | 0.78537223 |
| 125 | MP0009931_abnormal_skin_appearance | 0.78042899 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77349145 |
| 127 | MP0003941_abnormal_skin_development | 0.77183264 |
| 128 | MP0000681_abnormal_thyroid_gland | 0.77080072 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.76793680 |
| 130 | MP0003121_genomic_imprinting | 0.76771103 |
| 131 | MP0000858_altered_metastatic_potential | 0.76301046 |
| 132 | MP0004272_abnormal_basement_membrane | 0.76010347 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.75794927 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.75322222 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.73493852 |
| 136 | MP0000759_abnormal_skeletal_muscle | 0.73307356 |
| 137 | MP0003634_abnormal_glial_cell | 0.72778564 |
| 138 | MP0002092_abnormal_eye_morphology | 0.72614639 |
| 139 | MP0002210_abnormal_sex_determination | 0.72309077 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.71514832 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.71030980 |
| 142 | MP0000747_muscle_weakness | 0.70980527 |
| 143 | MP0003115_abnormal_respiratory_system | 0.69927545 |
| 144 | MP0003861_abnormal_nervous_system | 0.69772356 |
| 145 | MP0000266_abnormal_heart_morphology | 0.69451919 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.69347343 |
| 147 | MP0005501_abnormal_skin_physiology | 0.65916527 |
| 148 | MP0003453_abnormal_keratinocyte_physiol | 0.64198888 |
| 149 | MP0003186_abnormal_redox_activity | 0.63086562 |
| 150 | MP0005367_renal/urinary_system_phenotyp | 0.61493616 |
| 151 | MP0000516_abnormal_urinary_system | 0.61493616 |
| 152 | MP0008961_abnormal_basal_metabolism | 0.59381517 |
| 153 | MP0000432_abnormal_head_morphology | 0.59097196 |
| 154 | MP0000477_abnormal_intestine_morphology | 0.58464743 |
| 155 | MP0002089_abnormal_postnatal_growth/wei | 0.58429544 |
| 156 | MP0003448_altered_tumor_morphology | 0.58310201 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.55972536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ependymoma (HP:0002888) | 4.77707422 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.27908536 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.27908536 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.27908536 |
| 5 | Vertebral compression fractures (HP:0002953) | 4.09008562 |
| 6 | Abnormality of the astrocytes (HP:0100707) | 4.07728514 |
| 7 | Astrocytoma (HP:0009592) | 4.07728514 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 3.62514855 |
| 9 | Selective tooth agenesis (HP:0001592) | 3.53791035 |
| 10 | Multiple enchondromatosis (HP:0005701) | 3.51770355 |
| 11 | Ragged-red muscle fibers (HP:0003200) | 3.31854510 |
| 12 | Abnormality of the labia minora (HP:0012880) | 3.24599257 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.14037581 |
| 14 | Glioma (HP:0009733) | 3.12832394 |
| 15 | Hand muscle atrophy (HP:0009130) | 3.12274750 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.05622758 |
| 17 | Cholecystitis (HP:0001082) | 3.05622758 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.03458073 |
| 19 | Degeneration of anterior horn cells (HP:0002398) | 3.02967023 |
| 20 | Abnormality of the anterior horn cell (HP:0006802) | 3.02967023 |
| 21 | Breast hypoplasia (HP:0003187) | 3.01600835 |
| 22 | Rhabdomyosarcoma (HP:0002859) | 2.99219879 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.98230181 |
| 24 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.98029741 |
| 25 | Rib fusion (HP:0000902) | 2.94598151 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.89675445 |
| 27 | Adenoma sebaceum (HP:0009720) | 2.87166206 |
| 28 | Angiofibromas (HP:0010615) | 2.87166206 |
| 29 | Premature rupture of membranes (HP:0001788) | 2.86682440 |
| 30 | Short humerus (HP:0005792) | 2.84458402 |
| 31 | Trismus (HP:0000211) | 2.79430934 |
| 32 | Spinal muscular atrophy (HP:0007269) | 2.76783393 |
| 33 | Upper limb amyotrophy (HP:0009129) | 2.75050036 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.75050036 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 2.71128016 |
| 36 | Medulloblastoma (HP:0002885) | 2.70136594 |
| 37 | Neoplasm of striated muscle (HP:0009728) | 2.69132152 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68706045 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68706045 |
| 40 | Prolonged neonatal jaundice (HP:0006579) | 2.67224984 |
| 41 | Missing ribs (HP:0000921) | 2.66495743 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65495643 |
| 43 | Carpal bone hypoplasia (HP:0001498) | 2.61307847 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60938094 |
| 45 | Spastic diplegia (HP:0001264) | 2.58935724 |
| 46 | Petechiae (HP:0000967) | 2.57178758 |
| 47 | Loss of speech (HP:0002371) | 2.55012846 |
| 48 | Abdominal situs inversus (HP:0003363) | 2.52244685 |
| 49 | Abnormality of abdominal situs (HP:0011620) | 2.52244685 |
| 50 | Axonal loss (HP:0003447) | 2.50155010 |
| 51 | Colon cancer (HP:0003003) | 2.47974631 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.47589896 |
| 53 | Abnormal trabecular bone morphology (HP:0100671) | 2.46032501 |
| 54 | Microvesicular hepatic steatosis (HP:0001414) | 2.45871755 |
| 55 | Agnosia (HP:0010524) | 2.44084282 |
| 56 | Absent radius (HP:0003974) | 2.41766093 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 2.41481572 |
| 58 | Insomnia (HP:0100785) | 2.40308258 |
| 59 | Patellar aplasia (HP:0006443) | 2.40286265 |
| 60 | Hypokinesia (HP:0002375) | 2.39968565 |
| 61 | Neoplasm of the oral cavity (HP:0100649) | 2.39481573 |
| 62 | Upper motor neuron abnormality (HP:0002127) | 2.39162429 |
| 63 | Metaphyseal cupping (HP:0003021) | 2.34013243 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30113661 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30113661 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30113661 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.29258727 |
| 68 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.27003160 |
| 69 | Generalized amyotrophy (HP:0003700) | 2.26357152 |
| 70 | Shawl scrotum (HP:0000049) | 2.25769411 |
| 71 | Testicular atrophy (HP:0000029) | 2.24247168 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.23957368 |
| 73 | Aplasia involving forearm bones (HP:0009822) | 2.23722969 |
| 74 | Absent forearm bone (HP:0003953) | 2.23722969 |
| 75 | Basal cell carcinoma (HP:0002671) | 2.23470096 |
| 76 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.22163637 |
| 77 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.21793108 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.21650656 |
| 79 | Short nail (HP:0001799) | 2.21544518 |
| 80 | Cerebral hypomyelination (HP:0006808) | 2.21263478 |
| 81 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.20899070 |
| 82 | Increased connective tissue (HP:0009025) | 2.20780919 |
| 83 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.20254020 |
| 84 | Hyperparathyroidism (HP:0000843) | 2.19521103 |
| 85 | Impulsivity (HP:0100710) | 2.16193143 |
| 86 | Abnormality of the motor neurons (HP:0002450) | 2.15963578 |
| 87 | Abnormal neuron morphology (HP:0012757) | 2.15963578 |
| 88 | Oral leukoplakia (HP:0002745) | 2.14619577 |
| 89 | Purpura (HP:0000979) | 2.13516950 |
| 90 | Achilles tendon contracture (HP:0001771) | 2.13413592 |
| 91 | Abnormality of the umbilical cord (HP:0010881) | 2.11663914 |
| 92 | Difficulty climbing stairs (HP:0003551) | 2.11641551 |
| 93 | Increased serum ferritin (HP:0003281) | 2.08980444 |
| 94 | Nuclear cataract (HP:0100018) | 2.08778141 |
| 95 | Premature ovarian failure (HP:0008209) | 2.08507047 |
| 96 | Neoplasm of the pancreas (HP:0002894) | 2.07591649 |
| 97 | Microretrognathia (HP:0000308) | 2.06665678 |
| 98 | Progressive muscle weakness (HP:0003323) | 2.06255513 |
| 99 | Muscle fibrillation (HP:0010546) | 2.05534998 |
| 100 | Increased nuchal translucency (HP:0010880) | 2.05141764 |
| 101 | Rough bone trabeculation (HP:0100670) | 2.03870955 |
| 102 | Vertebral fusion (HP:0002948) | 2.03397753 |
| 103 | High anterior hairline (HP:0009890) | 2.02198959 |
| 104 | Fibroma (HP:0010614) | 2.01658598 |
| 105 | Biliary tract neoplasm (HP:0100574) | 2.01067191 |
| 106 | Genu recurvatum (HP:0002816) | 2.01058405 |
| 107 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.00950013 |
| 108 | Gastrointestinal carcinoma (HP:0002672) | 2.00950013 |
| 109 | Vertebral hypoplasia (HP:0008417) | 2.00796683 |
| 110 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.00796683 |
| 111 | Mucopolysacchariduria (HP:0008155) | 2.00676082 |
| 112 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00676082 |
| 113 | Rectovaginal fistula (HP:0000143) | 2.00294642 |
| 114 | Rectal fistula (HP:0100590) | 2.00294642 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.98727691 |
| 116 | Fused cervical vertebrae (HP:0002949) | 1.97743026 |
| 117 | Deviation of the thumb (HP:0009603) | 1.97559480 |
| 118 | Pseudobulbar signs (HP:0002200) | 1.97169584 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.97054124 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97054124 |
| 121 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96665173 |
| 122 | Protrusio acetabuli (HP:0003179) | 1.96480246 |
| 123 | Tongue fasciculations (HP:0001308) | 1.95900190 |
| 124 | Renal duplication (HP:0000075) | 1.95711742 |
| 125 | Absent thumb (HP:0009777) | 1.95386626 |
| 126 | Abnormality of glycolysis (HP:0004366) | 1.95020243 |
| 127 | Abnormal number of incisors (HP:0011064) | 1.94603106 |
| 128 | Proximal placement of thumb (HP:0009623) | 1.94438709 |
| 129 | Ankle contracture (HP:0006466) | 1.94233296 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93661203 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.93455329 |
| 132 | Hyperacusis (HP:0010780) | 1.93406024 |
| 133 | Ulnar bowing (HP:0003031) | 1.92070740 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.91851152 |
| 135 | Cafe-au-lait spot (HP:0000957) | 1.89523055 |
| 136 | Cortical dysplasia (HP:0002539) | 1.88276360 |
| 137 | Myopathic facies (HP:0002058) | 1.88117994 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87772254 |
| 139 | Cholelithiasis (HP:0001081) | 1.87668815 |
| 140 | Increased muscle lipid content (HP:0009058) | 1.87135005 |
| 141 | Cervical subluxation (HP:0003308) | 1.86362791 |
| 142 | Vaginal fistula (HP:0004320) | 1.84870651 |
| 143 | Fibrous tissue neoplasm (HP:0012316) | 1.83500226 |
| 144 | Diminished motivation (HP:0000745) | 1.83367965 |
| 145 | Fasciculations (HP:0002380) | 1.82614206 |
| 146 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81256019 |
| 147 | Personality changes (HP:0000751) | 1.81233379 |
| 148 | Back pain (HP:0003418) | 1.80029271 |
| 149 | Orthostatic hypotension (HP:0001278) | 1.79537454 |
| 150 | Abnormality of the salivary glands (HP:0010286) | 1.77100169 |
| 151 | Hypertensive crisis (HP:0100735) | 1.76958683 |
| 152 | Long palpebral fissure (HP:0000637) | 1.76726232 |
| 153 | Rhabdomyolysis (HP:0003201) | 1.76027951 |
| 154 | Atresia of the external auditory canal (HP:0000413) | 1.75947078 |
| 155 | Intestinal polyp (HP:0005266) | 1.75853236 |
| 156 | Preauricular skin tag (HP:0000384) | 1.75301629 |
| 157 | Delayed puberty (HP:0000823) | 1.75103129 |
| 158 | Elbow flexion contracture (HP:0002987) | 1.74558356 |
| 159 | Entropion (HP:0000621) | 1.74520535 |
| 160 | Cerebral inclusion bodies (HP:0100314) | 1.74335952 |
| 161 | EMG: neuropathic changes (HP:0003445) | 1.74284556 |
| 162 | Shallow orbits (HP:0000586) | 1.73939565 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.73557064 |
| 164 | Apathy (HP:0000741) | 1.73366389 |
| 165 | Skin tags (HP:0010609) | 1.72809982 |
| 166 | Vertebral clefting (HP:0008428) | 1.72136974 |
| 167 | Short 1st metacarpal (HP:0010034) | 1.71720465 |
| 168 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.71720465 |
| 169 | Uterine neoplasm (HP:0010784) | 1.71196484 |
| 170 | Reticulocytopenia (HP:0001896) | 1.70294660 |
| 171 | Increased serum pyruvate (HP:0003542) | 1.69526255 |
| 172 | Spinal rigidity (HP:0003306) | 1.69177892 |
| 173 | Spastic paraparesis (HP:0002313) | 1.68570836 |
| 174 | Growth hormone excess (HP:0000845) | 1.64310155 |
| 175 | Abnormal gallbladder morphology (HP:0012437) | 1.62721214 |
| 176 | Myocardial infarction (HP:0001658) | 1.62371139 |
| 177 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.62273366 |
| 178 | Bulbar palsy (HP:0001283) | 1.61848319 |
| 179 | Athetosis (HP:0002305) | 1.61687408 |
| 180 | Dysautonomia (HP:0002459) | 1.61141225 |
| 181 | Opisthotonus (HP:0002179) | 1.60964531 |
| 182 | Fatigue (HP:0012378) | 1.60903799 |
| 183 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.60428658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 3.54413095 |
| 2 | CDK12 | 3.37740278 |
| 3 | IRAK3 | 3.36673133 |
| 4 | VRK2 | 3.23626486 |
| 5 | SMG1 | 3.07633792 |
| 6 | BUB1 | 2.79805907 |
| 7 | EPHA2 | 2.75916209 |
| 8 | CDC7 | 2.72057219 |
| 9 | TRIB3 | 2.63581655 |
| 10 | WEE1 | 2.62491949 |
| 11 | PKN2 | 2.37220656 |
| 12 | NEK2 | 2.35757915 |
| 13 | SCYL2 | 2.29162715 |
| 14 | TESK2 | 2.21177887 |
| 15 | EEF2K | 2.07566382 |
| 16 | ICK | 2.04708095 |
| 17 | TTK | 2.02179416 |
| 18 | MAP3K10 | 1.93915737 |
| 19 | PRPF4B | 1.86204513 |
| 20 | STK16 | 1.80718037 |
| 21 | ALK | 1.66791952 |
| 22 | PLK1 | 1.65129381 |
| 23 | TESK1 | 1.63458421 |
| 24 | PAK4 | 1.62713118 |
| 25 | LATS2 | 1.60348206 |
| 26 | RPS6KB2 | 1.50867379 |
| 27 | CDK7 | 1.50602635 |
| 28 | SIK1 | 1.49342612 |
| 29 | BMX | 1.48902646 |
| 30 | LMTK2 | 1.46034920 |
| 31 | PASK | 1.40761180 |
| 32 | TSSK6 | 1.40674412 |
| 33 | DDR2 | 1.38036932 |
| 34 | KDR | 1.37512650 |
| 35 | MAP3K8 | 1.32144666 |
| 36 | MAP3K3 | 1.30540402 |
| 37 | PDGFRA | 1.29353174 |
| 38 | RIPK1 | 1.29185952 |
| 39 | TYRO3 | 1.28575140 |
| 40 | ABL2 | 1.27241326 |
| 41 | ERN1 | 1.22908799 |
| 42 | AURKA | 1.22150213 |
| 43 | PRKD3 | 1.17248526 |
| 44 | EIF2AK1 | 1.16168437 |
| 45 | MTOR | 1.15254317 |
| 46 | TBK1 | 1.15243534 |
| 47 | MAPKAPK3 | 1.14085515 |
| 48 | PBK | 1.14023196 |
| 49 | MAP3K11 | 1.13062074 |
| 50 | PDK4 | 1.09916112 |
| 51 | PDK3 | 1.09916112 |
| 52 | BRSK1 | 1.09075519 |
| 53 | CHEK2 | 1.06658373 |
| 54 | BRSK2 | 1.05922903 |
| 55 | CDK4 | 1.04100624 |
| 56 | AURKB | 1.03700012 |
| 57 | TLK1 | 1.03518764 |
| 58 | CHEK1 | 1.03027980 |
| 59 | TTN | 1.02037326 |
| 60 | MST1R | 1.01543772 |
| 61 | MAP3K9 | 0.99597673 |
| 62 | ATR | 0.99318409 |
| 63 | LATS1 | 0.98592790 |
| 64 | PLK3 | 0.96179856 |
| 65 | STK10 | 0.92861266 |
| 66 | LRRK2 | 0.90771645 |
| 67 | KSR2 | 0.88543060 |
| 68 | CDK2 | 0.84704178 |
| 69 | BCKDK | 0.83654802 |
| 70 | FLT3 | 0.82910221 |
| 71 | CDK6 | 0.79837343 |
| 72 | IRAK2 | 0.77430607 |
| 73 | PAK1 | 0.76624116 |
| 74 | DYRK3 | 0.75521490 |
| 75 | MAP3K1 | 0.75413561 |
| 76 | PRKCI | 0.75131703 |
| 77 | TAOK1 | 0.74335950 |
| 78 | PIM1 | 0.71861905 |
| 79 | PIM2 | 0.71055838 |
| 80 | AKT3 | 0.70390424 |
| 81 | NME2 | 0.69799898 |
| 82 | MOS | 0.69363052 |
| 83 | BRAF | 0.69147529 |
| 84 | MET | 0.68498331 |
| 85 | DAPK1 | 0.66675808 |
| 86 | RPS6KA4 | 0.64705471 |
| 87 | PRKD2 | 0.64593692 |
| 88 | AKT2 | 0.64053660 |
| 89 | MAP3K12 | 0.63727726 |
| 90 | SRPK1 | 0.61748575 |
| 91 | NTRK1 | 0.60199015 |
| 92 | PRKG2 | 0.59120208 |
| 93 | DAPK3 | 0.57933989 |
| 94 | EPHB2 | 0.56252476 |
| 95 | STK38L | 0.55756539 |
| 96 | PTK2 | 0.55572958 |
| 97 | DYRK1B | 0.55353092 |
| 98 | LIMK1 | 0.55125736 |
| 99 | SIK3 | 0.54002137 |
| 100 | ATM | 0.53311001 |
| 101 | CAMK2G | 0.52750075 |
| 102 | PDK2 | 0.52630735 |
| 103 | CSNK1E | 0.52018450 |
| 104 | PAK6 | 0.51845822 |
| 105 | ACVR1B | 0.51708791 |
| 106 | ARAF | 0.50683435 |
| 107 | RAF1 | 0.50612348 |
| 108 | CDK1 | 0.50123829 |
| 109 | TAOK2 | 0.49733852 |
| 110 | STK4 | 0.49403698 |
| 111 | MAP3K5 | 0.48914349 |
| 112 | GRK6 | 0.48794927 |
| 113 | MYLK | 0.48545922 |
| 114 | PTK6 | 0.48410210 |
| 115 | MATK | 0.48221609 |
| 116 | ERBB4 | 0.47980692 |
| 117 | BRD4 | 0.47903275 |
| 118 | ILK | 0.47152556 |
| 119 | PDPK1 | 0.46615209 |
| 120 | FGFR1 | 0.46405174 |
| 121 | RPS6KA1 | 0.45711236 |
| 122 | STK38 | 0.44453573 |
| 123 | CSNK2A2 | 0.43804552 |
| 124 | MAP2K3 | 0.43396926 |
| 125 | EPHB1 | 0.43144308 |
| 126 | PAK2 | 0.43067424 |
| 127 | MAPKAPK2 | 0.42897648 |
| 128 | CDC42BPA | 0.40931080 |
| 129 | CDK14 | 0.40523629 |
| 130 | CSNK1G3 | 0.40428438 |
| 131 | MAP4K1 | 0.39236338 |
| 132 | MAPK11 | 0.38943718 |
| 133 | PLK4 | 0.38469163 |
| 134 | STK3 | 0.38307099 |
| 135 | CDK8 | 0.38250800 |
| 136 | MAP2K2 | 0.36881035 |
| 137 | IRAK4 | 0.36594807 |
| 138 | CDK11A | 0.36519306 |
| 139 | RPS6KA2 | 0.33940351 |
| 140 | CDK15 | 0.33432023 |
| 141 | ZAP70 | 0.32091053 |
| 142 | CDK18 | 0.31127070 |
| 143 | ROCK2 | 0.28763853 |
| 144 | GSK3A | 0.25273646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.00756676 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.63262646 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.40723203 |
| 4 | RNA transport_Homo sapiens_hsa03013 | 3.27020575 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.09533234 |
| 6 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.05909476 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.74774349 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71890192 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.60488999 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.56478863 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.29030371 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27192639 |
| 13 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.18463420 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.09042917 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.96983715 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.95978746 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.91446770 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.87494690 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.86963490 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.77090011 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64880926 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.62793458 |
| 23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.61872554 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.61731670 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54771071 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.53872092 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44703536 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40232059 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38510974 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.38381396 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.36813786 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34894784 |
| 33 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.34718322 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31431631 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.30431868 |
| 36 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.30199395 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28945458 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23118608 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21801441 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20000485 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18558575 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.16898427 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16208695 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14137607 |
| 45 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.12413511 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.10989960 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10318509 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09889300 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09733833 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09436558 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07980263 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.07801989 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02276617 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99403890 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96713446 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95646003 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94729509 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93731065 |
| 59 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93702288 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85994818 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85976057 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84851907 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84269764 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.84225333 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83954818 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83894409 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83840823 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83587563 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81219220 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80673534 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79889166 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79748475 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77053827 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76491329 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76369710 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.76291739 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73978735 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73474528 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72107516 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.70672847 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68900783 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.68645116 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67404368 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66489995 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65117832 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64084280 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62182516 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62005396 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61452480 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61033256 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60703792 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60281607 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60013649 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59580952 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.58001519 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57710824 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.56883491 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56753050 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56438477 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55412900 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.55041458 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.54912512 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54322405 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.53845535 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53602071 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53277777 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52964816 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51728990 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48165258 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.47640057 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47206651 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45595695 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45368879 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44875167 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44819323 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.44412961 |
| 117 | Purine metabolism_Homo sapiens_hsa00230 | 0.43911880 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43716789 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42502703 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42005523 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40764539 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40714927 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38945506 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38267780 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37975225 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37216113 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36600071 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36256673 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.35410901 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.34894108 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.33924760 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33899575 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33744784 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.33533819 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32781270 |
| 136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32215447 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31180291 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29803820 |
| 139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.29441432 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28439727 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.28096387 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.25749661 |
| 143 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.25693669 |

